Canopy Growth Announces Plan to Acquire Leading U.S. Multi-State Cannabis Operator, Acreage Holdings

Canopy Growth宣布收购美国领先大麻运营商Acreage的计划

2019-04-19 07:30:00 PR Newswire


Proposed Deal Complements Canopy Growth's U.S. CBD Strategy With An Accelerated Pathway Into U.S. Cannabis Markets, Once Federally Permissible Deal Structure Expected to Provide Improved Access to Capital for Acreage, Paving Way for Accelerated Expansion SMITHS FALLS, ON and NEW YORK, April 18, 2019 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth") (WEED.TO) (CGC) and Acreage Holdings, Inc. ("Acreage") (CSE:ACGR.U) (ACRGF) (FSE:0ZV) (together, the "Companies") are pleased to announce that they have entered into a definitive arrangement agreement that grants Canopy Growth the right to acquire 100 percent of the shares of Acreage (the "Right"), with a requirement to do so at such time as cannabis production and sale becomes federally legal in the United States (the "Transaction"), subject to obtaining the requisite prior approval of the shareholders of each of Acreage and Canopy Growth, respectively (the "Shareholder Approval"), as well as the approval of the Supreme Court of British Columbia (the "Court Approval").  Following the approval of Canopy Growth and Acreage shareholders as well as the Supreme Court of British Columbia, under the terms of the arrangement agreement (the "Agreement"), Acreage Holders (as defined below) will receive an immediate aggregate total payment of US$300 million or approximately US$2.55 per Acreage Subordinate Voting Share (the "Up-Front Cash Premium") based on the currently outstanding Subordinate Voting Shares of Acreage and conversion of certain convertible ‎securities described below. In addition, upon the exercise of the Right, holders of subordinate voting shares of Acreage (the "Acreage Subordinate Voting Shares") will receive 0.5818 of a common share of Canopy Growth (the "Canopy Shares") for each Acreage Subordinate Voting Share held (the "Exchange Ratio") at the time of closing of the Transaction. Upon exercise of the Right, the total consideration payable pursuant to the Transaction is valued at approximately US$3.4 billion on a fully-diluted basis, represents a premium of 41.7% over the 30-day volume weighted average price of the Acreage Subordinate Voting Shares on the Canadian Securities Exchange (the "CSE") ending April 16, 2019 (based on the Exchange Ratio, Up-Front Cash Premium and the 30-day volume weighted average price of Canopy Shares as at April 16, 2019). The Companies will also execute a licensing agreement granting Acreage access to Canopy Growth's award-winning line-up of brands such as Tweed and Tokyo Smoke, along with other intellectual property. Once the Right is exercised, Acreage will become part of a leading global cannabis company with access to markets beyond the U.S. Until then, the two companies will continue to operate independently. "Today we announce a complex transaction with a simple objective. Our right to acquire Acreage secures our entrance strategy into the United States as soon as a federally-permissible pathway exists," said Bruce Linton, Chairman and co-CEO, Canopy Growth. "By combining Acreage's management team, licenses and assets with Canopy Growth's intellectual property and brands, there will be tremendous value creation for both companies' shareholders." "From the first day we created our company, providing exceptional customer care and delivering shareholder value have been our top priorities. This transaction will help accomplish both," said Acreage Holdings Chairman, CEO and President Kevin Murphy. "When the right is exercised having access to Canopy Growth's deep resources will enable us to innovate, develop and distribute quality cannabis brands across the U.S. and continue expanding our U.S. footprint. At the same time, a confluence of factors are making it much more difficult for a multi-state operator to achieve its full potential, including the enormous amount of cash required to scale. Our Board of Directors, management team and I are pleased to deliver significantly increased liquidity to our shareholders and put ourselves in an even stronger position to deliver continued and significant upside." Once the Right is exercised, the combined infrastructure, intellectual property, brands and organizational resources are expected to create a global cannabis powerhouse, with an anticipated leadership position in every targeted international market for legal cannabis sales, including the U.S., Canada, and select markets across Latin America, Europe and Asia-Pacific. Additional Information: Way More Detail The Transaction will be carried out by way of a court-approved plan of arrangement under the Business Corporations Act (British Columbia) (the "Arrangement") and will require the approval of shareholders of both Canopy Growth and Acreage at special meetings expected to take place in June 2019. In addition to shareholder approval, the Transaction is subject to applicable regulatory, court and stock exchange approvals and certain other closing conditions. Pursuant to the terms of the Transaction, the Acreage Subordinate Voting Shares, which may be acquired securities holders of proportionate voting shares of Acreage (the "Acreage Proportionate Voting Shares"), holders of multiple voting shares of Acreage (the "Acreage Multiple Voting Shares") and holders of units (the "Acreage Unit Holders") in High Street Capital Partners, LLC and shares of Acreage Holdings WC, Inc. (the "USCo2 Holders"), on conversion or exchange thereof, as applicable, will be subject to the Right and entitled to the Up-Front Cash Premium. Under the terms of the Agreement, Canopy Growth will pay the Up-Front Cash Premium to the holders of Acreage Subordinate Voting Shares, Acreage Proportionate Voting Shares and Acreage Multiple Voting Shares as well as Acreage Unit Holders and the USCo2 Holders (collectively, the "Acreage Holders"). There will be an Up-Front Cash Premium paid to the Acreage Holders based on the currently outstanding securities of Acreage. Following the federal legalization of cannabis in the United States (the "Triggering Event") and certain other conditions to closing, each Acreage Proportionate Voting Share and Acreage Multiple Voting Share will automatically convert into Acreage Subordinate Voting Shares in accordance with their terms and thereafter each Acreage Subordinate Voting Share will be automatically exchanged for Canopy Shares based on the Exchange Ratio. On closing of the Transaction, Acreage Unit Holders will have the right to convert their units, and USCo2 Holders will have the right to convert their shares, into Canopy Shares based on the Exchange Ratio. Acreage Unit Holders will be required to convert into Canopy Shares three years following the closing of the Transaction. If the Triggering Event is not satisfied or waived within 90 months from the payment of the Up-Front Cash Premium, the Agreement will terminate. After giving effect to the Transaction, assuming conversion of all securities of Acreage following a Triggering Event, Acreage Holders will hold approximately 12.1% ownership in Canopy Growth (on a pro forma basis) and up to 16.6% if permitted acquisitions are completed prior to the Trigger Event. Pursuant to the Transaction, Acreage is permitted to issue up to an additional 58,000,000 Acreage Subordinate Voting Shares (or the equivalent number of convertible securities), together with a further ‎5,221,905 Acreage Subordinate Voting Shares (or the equivalent number of convertible securities) in respect of certain potential acquisitions by Acreage‎. Constellation Brands Amendments Completion of the Transaction is conditional on the approval by holders of Canopy Shares of the issuance of the Canopy Shares pursuant to the Transaction and certain amendments to the existing warrants held by a subsidiary of Constellation Brands. Due to the scope of the proposed transaction, Canopy Growth and Constellation Brands have amended the investor rights agreement as outlined here: With these Amendments, Constellation continues using its cash flow to generate a return for its shareholders while Canopy Growth continues to deploy the USD $4 billion investment made by Constellation in November 2018. Acreage Board Recommendation The board of directors of Acreage (the "Acreage Board"), on the unanimous recommendation of a special committee of independent directors of Acreage (the "Acreage Special Committee"), has unanimously approved the Transaction and recommends that shareholders of Acreage vote in favour of the resolution to approve the Transaction. The Acreage Board and the special committee have obtained a fairness opinion from each of Canaccord Genuity Corp. and INFOR Financial Inc. that, as of the date of the respective opinions, and subject to the assumptions, limitations, and qualifications on which such opinions are based, the consideration to be received by Acreage Holders pursuant to the Transaction is fair, from a financial point of view, to the Acreage Holders. Acreage Shareholder Approval The Transaction requires approval by at least 66⅔% of the holders of the Acreage Subordinate Voting Shares, Acreage Proportionate Voting Shares and Acreage Multiple Voting Shares. Additionally, pursuant to Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions, the Transaction requires approval by at least a majority of disinterested holders of the Acreage Subordinate Voting Shares, Acreage Proportionate Voting Shares and Acreage Multiple Voting Shares, each voting separately as a class. Certain Acreage directors and officers have entered into voting and support agreements pursuant to which they have agreed, among other things, to vote in favor of the Transaction. The directors and officers of Acreage have also agreed to certain lock-up terms with respect to their current holdings of Acreage securities. Canopy Board Recommendation Greenhill & Co. Canada Ltd. ("Greenhill") acted as financial advisor to Canopy Growth and provided an independent fairness opinion to the board of directors of Canopy Growth (the "Canopy Board") that the Exchange Ratio payable pursuant to the Transaction is fair, from a financial point of view, to Canopy Growth. Upon receipt of the fairness opinion from Greenhill, the Transaction and the Amendments were unanimously approved by the Canopy Board, other than directors who abstained from voting on the transactions as a result of the Amendments. All Board members support the Transaction and the Amendments.   Canopy Shareholder Approval The issuance of the Canopy Shares in connection with the Transaction and certain of the amendments will require the approval of a simple majority of the disinterested shareholders of Canopy Growth present at a special meeting (the "Canopy Meeting"). Additional Transaction Terms The Transaction is subject to, among other things, approval from the CSE, the Toronto Stock Exchange and the New York Stock Exchange, the Supreme Court of British Columbia and certain other regulatory approvals and closing conditions. The Agreement contains representations, warranties and covenants, including a termination fee in the amount of US$150 million payable by Acreage in the event that the Transaction is terminated in certain circumstances. The Agreement also includes certain non-solicitation covenants subject to the right of Acreage to accept a superior proposal in certain circumstances, with Canopy Growth having a five-business day right to match any such superior proposal received by Acreage. Additional details of the Transaction and the Amendments will be provided to shareholders of Canopy Growth and Acreage in information circulars to be mailed to shareholders. Advisors Cassels Brock & Blackwell LLP and Paul Hastings LLP acted as legal counsel to Canopy Growth. PricewaterhouseCoopers LLP (Canada) acted as finance advisor to Canopy Growth. Ernst & Young LLP (EY) acted as tax advisors to Canopy Growth. DLA Piper (Canada) LLP and Cozen O'Connor acted as legal counsel to Acreage. Canaccord Genuity Corp. acted as financial advisor to Acreage and INFOR Financial Inc. acted as financial advisor to the special committee of Acreage. Canaccord Genuity Corp. and INFOR Financial Inc. provided a fairness opinion to the Acreage Board and the Acreage Special Committee respectively. Stikeman Elliott LLP acted as legal counsel to the Acreage Special Committee. About Canopy GrowthCanopy Growth is a world-leading diversified cannabis and hemp company, offering distinct brands and curated cannabis varieties in dried, oil and Softgel capsule forms. Canopy Growth offers medically approved vaporizers through its subsidiary, Storz & Bickel GMbH & Co. KG. From product and process innovation to market execution, Canopy Growth is driven by a passion for leadership and a commitment to building a world-class cannabis company one product, site and country at a time. Canopy Growth has operations in over a dozen countries across five continents. Canopy Growth is proudly dedicated to educating healthcare practitioners, conducting robust clinical research, and furthering the public's understanding of cannabis, and through its wholly owned subsidiary, Canopy Health Innovations, has devoted millions of dollars toward cutting edge, commercializable research and IP development. Canopy Growth works with the Beckley Foundation and has launched Beckley Canopy Therapeutics to research and develop clinically validated cannabis-based medicines, with a strong focus on intellectual property protection. Canopy Growth acquired assets of leading hemp research company, ebbu, Inc. ("ebbu"). Intellectual Property ("IP") and R&D advancements achieved by ebbu's team apply directly to Canopy Growth's hemp and THC-rich cannabis genetic breeding program and its cannabis-infused beverage capabilities. Through partly owned subsidiary Canopy Rivers Inc., Canopy Growth is providing resources and investment to new market entrants and building a portfolio of stable investments in the sector. From our historic public listing on the Toronto Stock Exchange and New York Stock Exchange to our continued international expansion, pride in advancing shareholder value through leadership is engrained in all we do at Canopy Growth. Canopy Growth has established partnerships with leading sector names including cannabis icon Snoop Dogg, breeding legends DNA Genetics and Green House seeds, Battelle, the world's largest nonprofit research and development organization, and Fortune 500 alcohol leader Constellation Brands, to name but a few. Canopy Growth operates ten licensed cannabis production sites with over 4.4 million square feet of production capacity, including over 500,000 square feet of GMP certified production space. For more information visit About AcreageHeadquartered in New York City, Acreage is the largest vertically integrated, multi-state owner of cannabis licenses and assets in the U.S. with respect to the number of states with cannabis related licenses, according to publicly available information. Acreage owns licenses to operate or has management services agreements in place with license holders to assist in operations in 20 states (including pending acquisitions) with a population of approximately 180 million Americans, and an estimated 2022 total addressable market of more than $17 billion in legal cannabis sales, according to Arcview Market Research. Acreage is dedicated to building and scaling operations to create a seamless, consumer-focused branded cannabis experience. Acreage's national retail store brand, The Botanist, debuted in 2018. Forward-Looking StatementThis news release contains "forward-looking statements" within the meaning of the United States Private Securities Litigation Reform Act of 1995 and "forward-looking information" within the meaning of applicable Canadian securities legislation. Often, but not always, forward-looking statements and information can be identified by the use of words such as "plans", "expects" or "does not expect", "is expected", "estimates", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Forward-looking statements or information involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Canopy Growth, Acreage or their respective subsidiaries to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements or information contained in this news release. These forward-looking statements include, but are not limited to, statements relating to our expectations with respect to: the timing and outcome of the Transaction; the anticipated benefits of the Transaction to the parties and their respective security holders; impact of the Transaction and anticipated growth of the combined entity; and the anticipated timing of the Meeting. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information, including assumptions as to the time required to prepare and mail security holder meeting materials; the ability of the parties to receive, in a timely manner and on satisfactory terms, the necessary regulatory, court and shareholder approvals; the ability of the parties to satisfy, in a timely manner, the other conditions; the likelihood of the Triggering Event being satisfied or waived by the outside date; the ability of the parties to satisfy, in a timely manner, the conditions to closing following the satisfaction or waiver of the Triggering Event; other expectations and assumptions concerning the Transaction; and such risks contained in Canopy Growth's annual information form dated June 28, 2018 and in Acreage's annual information form dated February 14, 2019 and filed with Canadian securities regulators available on Canopy Growth and Acreage's respective issuer profiles on SEDAR at Readers are cautioned that the foregoing list of factors is not exhaustive. In respect of the forward-looking statements and information concerning the anticipated benefits and completion of the Transaction and the anticipated timing for completion of the Transaction, Canopy Growth and Acreage have provided such statements and information in reliance on certain assumptions that they believe are reasonable at this time. Although Canopy Growth and Acreage believe that the assumptions and factors used in preparing the forward-looking information or forward-looking statements in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information and forward-looking statements included in this news release are made as of the date of this news release and Canopy Growth and Acreage do not undertake an obligation to publicly update such forward-looking information or forward-looking information to reflect new information, subsequent events or otherwise unless required by applicable securities laws. There can be no assurance that the Transaction, including the Triggering Event, will occur, or that it will occur on the terms and conditions contemplated in this news release. The Transaction could be modified, restructured or terminated. Actual results could differ materially from those currently anticipated due to a number of factors and risks. The Transaction cannot close until the required shareholder, court and regulatory approval is obtained. There can be no assurance that the Transaction will be completed as proposed or at all. Investors are cautioned that, except as disclosed in the management information circulars to be prepared in connection with the Transaction, any information released or received with respect to the Transaction may not be accurate or complete and should not be relied upon. The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release. multimedia:
拟议的交易补充了 Canopy Growth 的美国 CBD 战略,该战略将加速进入美国 Cannabis 市场,一旦获得联邦许可 交易结构有望为 Acreage 提供更好的融资渠道,为加速扩张铺平道路 SMITHS FALLS , ON and New York ,2019年4月18日/ PRNewswire /- Canopy Growth Corporation (" Canopy Growth ")( WEED.TO )( CGC )和 Acreage Holdings , Inc .(" Acreage ")( CSE : ACGR.U )( ACRGF )( FSE :0 ZV )(合"公司")高兴地宣布,它们已达成一项最终安排协议,授予 Canopy Growth 收购 Acreage 100%股份的权利("权利"),并要求在大麻生产和销售在美国成为联邦法律时这样做("交易"),前提是分别获得 Acreage 和 Canopy Growth 各自股东的必要事先批准("股东批准"),以及不列颠哥伦比亚省最高法院的批准("法院批准")。 在 Canopy Growth 和 Acreage 股东以及不列颠哥伦比亚省最高法院根据安排协议(“协议”)的条款批准之后,Acreage 持有人(定义见下文)将根据目前尚未行使的 Acreage 次级投票权股份及下文所述若干可换股证券的转换,即时收取总额为300,000,000美元或每股 Acreage 次级投票权股份约2.55美元的总付款(「前期现金溢价」)。此外,于行使该权利时, Acreage 之次级投票权股份(「 Acreage Subordinable Voting Shares 」)之持有人将于交易结束时就所持有之各 Acreage Subordinate 投票权股份(「交换率」)收取 Canopy Growth 之普通股(「 Canopy Shares 」)0.5818。行使该权利后,根据交易应付之总代价按全面摊薄基准计算约为34亿美元,较截至4月16日止加拿大证券交易所(「 CSE 」) Acreage Suborder Voices 之30天成交量加权平均价格溢价41.7%。二零一九年(按交换比率、先旧现金溢价及 Canopy 股份于二零一九年四月十六日之30天成交量加权平均价格计算)。 两家公司还将签署一项许可协议,允许 Acreage 使用 Canopy Growth 旗下的 Tweed 和 Tokyo Smoke 等获奖品牌以及其他知识产权。一旦这项权利得到行使, Acreage 将成为全球领先的大麻公司的一部分,可以进入美国以外的市场。在此之前,这两家公司将继续独立运营。 “今天我们宣布了一个简单目标的复杂交易。我们获得 Acreage 的权利确保了我们的进入战略,一旦联邦许可的途径存在,我们就进入美国,” BruceLinton 说,董事长兼联席首席执行官, Canopy Growth 。通过将 Acreage 的管理团队、许可和资产与 Canopy Growth 的知识产权和品牌相结合,将为两家公司的股东创造巨大的价值。 “从我们创建公司的第一天起,提供卓越的客户关怀和提供股东价值一直是我们的首要任务。Acreage 控股公司董事长、首席执行官兼总裁 Kevin Murphy 说:“这一交易将有助于实现这两个目标。”“如果行使这项权利,能够获得 Canopy Growth 的深厚资源,我们将能够在美国各地创新、开发和分销优质大麻品牌,并继续扩大我们在美国的业务。与此同时,各种因素的融合使得多国运营商更难实现其全部潜力,包括规模所需的巨额现金。我们的董事会、管理团队和我很高兴向我们的股东提供大幅增加的流动性,并使我们处于更强大的地位,以实现持续和显著的上升。” 一旦这项权利得到行使,基础设施、知识产权、品牌和组织资源的结合预计将创造一个全球大麻强国,在包括美国、加拿大在内的合法大麻销售的每个目标国际市场上都具有预期的领导地位,并在整个拉丁美洲选定市场,欧洲和亚太地区. 补充资料: 方法更多详细信息 该交易将通过法院批准的《商业公司法》(不列颠哥伦比亚省)(“该安排”)下的安排计划进行,并将要求 Canopy Growth 和 Acreage 的股东在预计于2019年6月举行的特别会议上批准。除股东批准外,本次交易尚须遵守适用的监管、法院及证券交易所批准及若干其他关闭条件。 根据交易之条款, Acreage Subordinable Voting Shares (可收购 Acreage 之比例投票权股份(「 Acreage 比例投票权股份」)之证券持有人)Acreage ( Acreage Multiple Voting Shares )的多个有表决权股份的持有人以及 High Street Capital Partners , LLC 的单位持有人(“ Acreage Unit Holders ”)和 Acreage Holdings WC , Inc .(以下简称“ USCo2 Holders ”)在转换或交换时的股份(如适用),将受该权利制约,并有权获得前期现金溢价。 根据该协议的条款, Canopy Growth 将向 Acreage Suborder Voting Shares 、 Acreage Proported Voting Shares 和 Acreage Multi Voting Shares 以及 Acreage Unit Holders 和 USCo2 Holders (统称为“ Acreage Holders ”)的持有人支付前期现金溢价。将根据 Acreage 的当前未偿还证券向 Acreage 持有人支付预付现金溢价。 在美国大麻的联邦合法化(“触发事件”)和某些其他关闭条件之后,各 Acreage 比例投票权股份及 Acreage 多重投票权股份将根据其条款自动转换为 Acreage Suborder 投票权股份,其后各 Acreage Suborder 投票权股份将根据交换比率自动交换 Canopy 股份。于交易完成时, Acreage 单位持有人将有权转换其单位,而 USCo2持有人将有权根据交换比率将其股份转换为 Canopy 股份。于交易完成后三年, Acreage 单位持有人须转换为 Canopy 股份。如果触发事件未能在支付前期现金溢价后90个月内得到满足或豁免,则本协议终止。 于交易生效后,假设于触发事件后转换 Acreage 之所有证券, Acreage 持有人将持有 Canopy Growth (按备考基准)约12.1%之所有权,及于触发事件前完成许可收购最多16.6%。根据交易, Acreage 获准发行最多58,000,000股 Acreage Subordinable Voices Shares (或相当数量的可转换证券),连同另5,221,905股 Acreage Suborder Voices (或相当数量的可转换证券)就 Acreage 的若干潜在收购而发行。 星座品牌修订 完成交易须待 Canopy 股份持有人批准根据交易发行 Canopy 股份及对 Constellation Brands 附属公司持有的现有认股权证作出若干修订后,方可作实。由于本次拟交易的范围, Canopy Growth 与 Constellation Brands 已对投资者权利协议进行了如下修订: 通过这些修正案,星座公司继续利用其现金流为股东创造回报,而 Canopy Growth 继续部署星座公司在2018年11月作出的40亿美元投资。 认可委员会的建议 Acreage 董事会(「 Acreage 董事会」)根据 Acreage 独立董事特别委员会(「 Acreage 特别委员会」)之一致推荐,一致批准本次交易,并建议 Acreage 股东投票赞成批准本次交易的决议案。 Acreage 董事会和特别委员会已从 Canaccord Genuity Corp .和 INFOR Financial Inc .各自获得公平意见,认为截至各自意见发表之日,并受这些意见所依据的假设、限制和限定条件的制约,从财务角度看, Acreage Holders 根据交易收取的代价对 Acreage Holders 而言属公平。 批准股东批准 本次交易尚需取得 Acreage Suborder Voting Shares 、 Acreage Proported Voting Shares 及 Acreage Multiple Voting Shares 至少66,8532%的持有人的批准。此外,根据第61-101号多边文书-保护特殊交易中的少数股东证券持有人,该交易要求至少大多数未利害关系的 Acreage Sub纵坐标投票权股份、 Acreage 比例投票权股份和 Acreage 多重投票权股份持有人批准,每一类别分别投票。 若干接纳董事及高级人员已订立投票及支持协议,据此,彼等已同意(其中包括)投票赞成交易。Acreage 的董事及高级职员亦同意就其目前持有的 Acreage 证券订立若干锁定条款。 Canopy Board 建议 Greenhill & Co . Canada Ltd .(「 Greenhill 」)担任 Canopy Growth 的财务顾问,并向 Canopy Growth 的董事会(「 Canopy 董事会」)提供独立公平意见,认为根据交易应付的汇率,从财务角度而言,对 Canopy Growth 而言属公平。于接获 Greenhill 之公平意见后,交易及该等修订已获 Canopy 董事会一致通过,惟因该等修订而放弃就该等交易投票之董事除外。所有董事会成员均支持交易及修订。 大股东批准 就交易及若干修订事项发行 Canopy 股份将须于股东特别大会(「 Canopy 大会」)上获出席 Canopy Growth 之非利害关系股东简单多数批准。 其他交易条款 交易须待(其中包括) CSE 、多伦多证券交易所及纽约证券交易所、英属哥伦比亚最高法院及若干其他监管批准及关闭条件批准后方可进行。协议包含陈述、保证和契约,包括在交易在某些情况下终止时 Acreage 应支付的1.5亿美元终止费。该协议还包括某些非邀约,但须符合 Acreage 在某些情况下接受上级建议的权利, Canopy Growth 有五个工作日的权利与 Acreage 收到的任何此类高级建议相匹配。 将向 Canopy Growth 和 Acreage 的股东提供有关交易和修订的其他详细信息,并将其发送给股东。 顾问公司 CasselsBrock & Blackwell LLP 和 PaulHastings LLP 担任 Canopy Growth 的法律顾问。普华永道会计师事务所(加拿大)担任 Canopy Growth 的财务顾问。安永会计师事务所(安永)担任 Canopy Growth 的税务顾问。DLA Piper (加拿大) LLP 和 Cozen O'Connor 担任 Acreage 的法律顾问。Canaccord Genuity Corp .担任 Acreage 的财务顾问, INFORF Financial Inc .担任 Acreage 专门委员会的财务顾问。Canaccord Genuity Corp .和 INFOR Financial Inc .分别向 Acreage 董事会和 Acreage 特别委员会提供了公平意见。Stikeman Elliott LLP 担任 Acreage 特别委员会的法律顾问。 关于 Canopy Growth Canopy Growth 是一家全球领先的多元化大麻和大麻公司,以干、油和软胶囊的形式提供不同的品牌和疗效显著的大麻品种。 Canopy Growth 通过其子公司 Storz & Bickel GMbH & Co . KG 提供医学认可的汽化器。从产品和工艺创新到市场执行, Canopy Growth 是由对领导的热情和致力于建立一个世界级的大麻公司一次产品,地点和国家。Canopy Growth 在五大洲的十几个国家开展业务。 Canopy Growth 自豪地致力于教育医疗保健从业者,开展强有力的临床研究,促进公众对大麻的了解,并通过其全资子公司 Canopy Health Innovations 投入了数百万美元用于前沿、商业化研究和知识产权开发。Canopy Growth 与 Beckley 基金会合作,推出了 Beckley Canopy Therapeutics ,用于研究和开发基于临床验证的大麻药物,并大力注重知识产权保护。Canopy Growth 收购了领先的大麻研究公司 ebbu , Inc .(" ebbu ")的资产。ebbu 团队取得的知识产权( IP )和研发进展直接应用于 Canopy Growth 的大麻和富含 THC 的大麻基因育种计划及其大麻输液饮料能力。Canopy Growth 通过部分控股的子公司 Canopy Rivers Inc .向新进入市场的企业提供资源和投资,并在该行业建立稳定的投资组合。 从多伦多证券交易所( Toronto Stock Exchange )和纽约证券交易所( New York Stock Exchange )历史上的公开上市,到我们持续的国际扩张,我们对通过领导力提升股东价值感到自豪,这是我们在 Canopy Growth 所做的一切。Canopy Growth 与大麻图标 Snoop Dogg 、育种传奇人物 DNA 遗传学和绿屋种子、全球最大的非盈利研发组织 Battelle 以及《财富》500强酒精领袖星座品牌等知名行业建立了合作关系。Canopy Growth 经营着10个有执照的大麻生产场所,拥有超过440万平方英尺的生产能力,包括超过50万平方英尺的 GMP 认证生产场所。有关详细信息,请访问 。 关于 AcreageHead 位于纽约市,根据公开的信息, Acreage 是美国拥有大麻相关许可证的州数量最大的纵向一体化、多州大麻许可证和资产的所有者。Acreage 拥有经营许可证或与许可证持有者签订管理服务协议,以协助在20个州开展业务(包括正在进行的收购),人口约为1.8亿美国人,估计2022年可进入的合法大麻销售市场总额超过170亿美元。根据 Arcview 市场研究。Acreage 致力于构建和扩展业务,以创造无缝的、以消费者为中心的品牌大麻体验。Acreage 的全国零售商店品牌 The Botanist 于2018年首次亮相。 前瞻性陈述本新闻稿包含1995年美国私人证券诉讼改革法案意义内的“前瞻性陈述”和适用加拿大证券立法意义内的“前瞻性信息”。通常但并非总是,前瞻性陈述和信息可以通过使用诸如“计划”、“预期”或“不预期”、“预期”、“估计”、“意图”、“预期”或“不预期”或“相信”等词和短语或陈述某些行动、事件或结果“可能”、“可能”、“将”的变化来识别。"可能"或"将"采取、发生或实现。前瞻性陈述或信息涉及已知和未知的风险、不确定性和其他因素,可能导致 Canopy Growth 、 Acreage 或其各自子公司的实际业绩、业绩或业绩与任何未来业绩产生重大差异。本新闻稿所载前瞻性陈述或信息所表达或暗示的业绩或成就。这些前瞻性陈述包括但不限于:有关我们对以下方面的预期的声明:交易的时间和结果;交易对各方及其各自证券持有人的预期利益;交易的影响和合并实体的预期增长;以及会议的预期时间。 与前瞻性信息相关的风险、不确定性和其他因素可能导致实际事件、结果、业绩、前景和机会与此类前瞻性信息明示或暗示的情况存在重大差异,包括有关准备和邮寄证券持有人会议材料所需时间的假设;各方及时并以令人满意的条款收到必要的监管、法院和股东批准的能力;各方及时满足其他条件的能力;触发事件在外部日期之前得到满足或豁免的可能性;各方及时满足的能力;达成或豁免触发事件后的终止条件;有关该交易的其他预期和假设;以及 Canopy Growth 日期为2018年6月28日的年度信息表和 Acreage 日期为2019年2月14日的年度信息表中包含的风险,并向加拿大证券监管机构提交了关于 Canopy Growth 和 Acreage 各自在 SEDAR 上的发行人概况的资料,网址为 。读者应注意,上述因素列表并非详尽无遗。 就有关预期收益及交易完成之资料及预期完成交易之时间之前瞻性陈述及资料, Canopy Growth 及 Acreage 已根据彼等当时认为合理之若干假设提供该等陈述及资料。尽管 Canopy Growth 和 Acreage 认为,在编制本新闻稿中的前瞻性信息或前瞻性陈述时所使用的假设和因素是合理的,但不应过分依赖此类信息,也不能保证此类事件将在披露的时间框架内或任何时候发生。本新闻稿中包含的前瞻性信息和前瞻性声明是在本新闻稿发布之日做出的, Canopy Growth 和 Acreage 不承担公开更新此类前瞻性信息或前瞻性信息以反映新信息的义务。后续事件或其他,除非适用的证券法要求。 无法保证交易(包括触发事件)将发生,或交易将根据本新闻稿中预期的条款和条件发生。交易可以修改、重组或终止。由于若干因素和风险,实际结果可能与目前预计的结果有重大差异。 在获得所需股东、法院及监管机构批准之前,交易无法完成。无法保证交易将按提议完成或完全完成。投资者务请注意,除将编制有关交易之管理资料通函所披露外,有关交易之任何已披露或收到之资料可能并不准确或完整,亦不应依赖该等资料。 加拿大证券交易所未对本新闻稿内容进行审核、批准或否决。 多媒体:英亩控股-300834628。html